Excluding myeloma diagnosis using revised thresholds for serum free light chain ratios and M-protein levels | Haematologica
![Kappa free light chain index as a diagnostic biomarker in multiple sclerosis: A real‐world investigation - Rosenstein - 2021 - Journal of Neurochemistry - Wiley Online Library Kappa free light chain index as a diagnostic biomarker in multiple sclerosis: A real‐world investigation - Rosenstein - 2021 - Journal of Neurochemistry - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/758823d2-3999-4c81-a65e-625144b1e8d3/jnc15500-fig-0006-m.jpg)
Kappa free light chain index as a diagnostic biomarker in multiple sclerosis: A real‐world investigation - Rosenstein - 2021 - Journal of Neurochemistry - Wiley Online Library
![PDF] Serum free light chain ratio, total kappa/lambda ratio, and immunofixation results are not prognostic factors after stem cell transplantation for newly diagnosed multiple myeloma. | Semantic Scholar PDF] Serum free light chain ratio, total kappa/lambda ratio, and immunofixation results are not prognostic factors after stem cell transplantation for newly diagnosed multiple myeloma. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/92e61d19dc92e499c7b7b01818ac923837d9f518/2-Table1-1.png)
PDF] Serum free light chain ratio, total kappa/lambda ratio, and immunofixation results are not prognostic factors after stem cell transplantation for newly diagnosed multiple myeloma. | Semantic Scholar
Comparison of serum free light chain and urine electrophoresis for the detection of the light chain component of monoclonal immunoglobulins in light chain and intact immunoglobulin multiple myeloma | Haematologica
Prognostic utility of serum free light chain ratios and heavy-light chain ratios in multiple myeloma in three PETHEMA/GEM phase III clinical trials | PLOS ONE
![PDF] Polyclonal free light chains: a biomarker of inflammatory disease or treatment target? | Semantic Scholar PDF] Polyclonal free light chains: a biomarker of inflammatory disease or treatment target? | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/091b9510bd72aa951da79457a27309803520cd7e/2-Figure1-1.png)
PDF] Polyclonal free light chains: a biomarker of inflammatory disease or treatment target? | Semantic Scholar
![PDF] Serum free light chain ratio, total kappa/lambda ratio, and immunofixation results are not prognostic factors after stem cell transplantation for newly diagnosed multiple myeloma. | Semantic Scholar PDF] Serum free light chain ratio, total kappa/lambda ratio, and immunofixation results are not prognostic factors after stem cell transplantation for newly diagnosed multiple myeloma. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/92e61d19dc92e499c7b7b01818ac923837d9f518/2-Table2-1.png)
PDF] Serum free light chain ratio, total kappa/lambda ratio, and immunofixation results are not prognostic factors after stem cell transplantation for newly diagnosed multiple myeloma. | Semantic Scholar
![Edgar V. Lerma 🇵🇭 on Twitter: "Serum Free Light Chain Test for Monoclonal Gammopathy #Nephpearls https://t.co/2tcoDessPu http://t.co/O32qFJH9AD" / Twitter Edgar V. Lerma 🇵🇭 on Twitter: "Serum Free Light Chain Test for Monoclonal Gammopathy #Nephpearls https://t.co/2tcoDessPu http://t.co/O32qFJH9AD" / Twitter](https://pbs.twimg.com/media/BzpapUAIIAAdvah.jpg)
Edgar V. Lerma 🇵🇭 on Twitter: "Serum Free Light Chain Test for Monoclonal Gammopathy #Nephpearls https://t.co/2tcoDessPu http://t.co/O32qFJH9AD" / Twitter
![Serum free light chain assays not total light chain assays are the standard of care to assess Monoclonal Gammopathies - ScienceDirect Serum free light chain assays not total light chain assays are the standard of care to assess Monoclonal Gammopathies - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S151684841500170X-gr1.jpg)
Serum free light chain assays not total light chain assays are the standard of care to assess Monoclonal Gammopathies - ScienceDirect
![Polyclonal serum free light chain elevation is associated with increased risk of monoclonal gammopathies | Blood Cancer Journal Polyclonal serum free light chain elevation is associated with increased risk of monoclonal gammopathies | Blood Cancer Journal](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41408-019-0210-z/MediaObjects/41408_2019_210_Fig1_HTML.png)